3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Colorectal Neoplasms
12
Breast Neoplasms
10
Lung Neoplasms
9
Neoplasms
8
Uterine Cervical Neoplasms
7
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Colorectal Cancer Screening
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Head and Neck Neoplasms
1
Interventions
Cyclophosphamide
18
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
13
Cyclosporine
12
Whole-Body Irradiation
11
Antilymphocyte Serum
10
fludarabine
9
Exercise
9
Busulfan
9
Mycophenolic Acid
8
Melphalan
8
Dexamethasone
8
Blood Specimen Collection
8
Filgrastim
7
Standard of Care
6
Radiotherapy
6
Behavior Therapy
6
Acupuncture Therapy
6
Therapeutics
5
Specimen Handling
5
Palliative Care
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Educational Status
5
Surveys and Questionnaires
4
Stem Cell Transplantation
4
Psychiatric Rehabilitation
4
Practice Guidelines as Topic
4
Methylprednisolone
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Multiple Myeloma
×
Patient Navigation
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts